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There is growing interest in the role of bone in knee
osteoarthritis. Bone is a dynamic organ, tightly regulated
by a multitude of homeostatic controls, including
genetic and environmental factors. One such key
environmental regulator of periarticular bone is
mechanical stimulation, which, according to Wolff’s law,
is a key determinant of bone properties. Wolff’s law
theorizes that repetitive loading of bone will cause
adaptive responses enabling the bone to better cope
with these loads. Despite being an adaptive response of
bone, the remodeling process may inadvertently trigger
maladaptive responses in other articular structures.
Accumulating evidence at the knee suggests that
expanding articular bone surface area is driven by
mechanical stimulation and is a strong predictor of
articular cartilage loss. Similarly, fractal analysis of bone
architecture provides further clues that bone adaptation
may have untoward consequences for joint health. This
review hypothesizes that adaptations of periarticular
bone in response to mechanical stimulation cause
maladaptive responses in other articular structures that
mediate the development of knee osteoarthritis. A
potential disease paradigm to account for such a
hypothesis is also proposed, and novel therapeutic
targets that may have a bone-modifying effect, and
therefore potentially a disease-modifying effect, are also
explored.* Correspondence: flavia.cicuttini@monash.edu
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Historically, osteoarthritis (OA) had been considered a
disease predominantly affecting articular cartilage. More
recently, it has been appreciated that OA affects the en-
tire joint and all of its constituent tissues and that a
spectrum of structural changes ranges from early asymp-
tomatic disease detected on magnetic resonance imaging
(MRI) to painful end-stage radiographic disease requir-
ing joint replacement surgery.
There is growing recognition for the role of bone in
both early- and late-stage knee OA. Indeed, radiographic
criteria for the diagnosis of OA developed in the 1950s
included subchondral sclerosis and osteophytes as hall-
marks of disease [1]. In the spectrum of knee OA, radio-
graphic changes represent advanced disease, but these
evolve over a period of time. Earlier changes in bone are
likely to occur before radiographic disease is evident.
Bone is a dynamic tissue that is tightly regulated by a
multitude of homeostatic controls. One key environ-
mental regulator of periarticular bone is mechanical
stimulation. Wolff ’s law relates to the response of bone
to mechanical stimulation and states that bony adaptation
will occur in response to a repeated load [2]. It is interest-
ing to consider this in the setting of knee OA, which has a
strong biomechanical component to its etiology.
When periarticular bone is subjected to increased
loading, a number of bone properties change. These in-
clude, but are not limited to, an expanding subchondral
bone cross-sectional area, changes in bone mass, and re-
modeling of the trabeculae network. Although these
changes likely represent appropriate homeostatic re-
sponses of bone to increased loading, they also appear
to inadvertently predate maladaptive responses in other
articular structures, most notably cartilage. For instance,
animal studies have demonstrated that surgical damage
to subchondral bone leads to degradation in the overly-
ing articular cartilage in dogs [3] but that increased
thickness of the subchondral bone occurs prior to anyticle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Teichtahl et al. Arthritis Research & Therapy  (2015) 17:207 Page 2 of 9histologic evidence of cartilage degradation in a guinea
pig model of spontaneously occurring knee OA [4].
This review hypothesizes that adaptations of periarticu-
lar bone in response to mechanical stimulation cause
maladaptive responses in other articular structures that
mediate the development of knee OA. Furthermore,
this review explores one potential mechanism hypothesiz-
ing how bony adaptation to increased mechanical load
may inadvertently predate early knee OA. Novel thera-
peutic agents that may have a bone-modifying effect, and
therefore potentially a disease-modifying effect, are also
explored.
Wolff’s law and mechanotransduction
Julius Wolff (1836–1902), a German anatomist and sur-
geon, theorized that bone will adapt to the repeated
loads under which it is placed [2]. He proposed that, if
load to a bone increases, remodeling will occur so that the
bone is better equipped to resist such loads. Likewise, he
hypothesized that, if load to a bone decreases, homeostatic
mechanisms will shift toward a catabolic state, and bone
will be equipped to withstand only the loads to which it is
subjected.
It is now recognised that remodeling of bone in response
to a load occurs via sophisticated mechanotransduction
mechanisms. These are processes whereby mechanical
signals are converted via cellular signaling to biochemical
responses [5]. The key steps involved in these processes
include mechanocoupling, biochemical coupling, signal
transmission, and cell response [6].
Wolff’s law in action at the knee
Some of the most convincing evidence to substantiate
the role of Wolff ’s law at the knee has been derived from
animal models. Mice with varying loads applied to the tibial
diaphysis demonstrated that knee loading was an effective
means of enhancing bone formation in a loading
frequency-dependent manner [7]. Likewise, a recent mouse
study examined an in vivo tibial loading model to deter-
mine the adaptive responses of bone to mechanical loading
and to assess the influence of load and duration [8]. Cyclic
compressive loads were applied to the left tibial knee joint
of adult and young mice for 1, 2, and 6 weeks. Mechanical
loading promoted increased metaphyseal bone mass in
young mice but not in adult mice.
Subchondral cross-sectional area of bone
Biomechanical variables and subchondral bone cross-
sectional area
Among humans, some of the earliest work linking knee
joint loads and bone adaptation in vivo was born from
gait analyses. Gait analyses enable biomechanical variables
that estimate knee joint loads to be examined from force
platforms. For instance, the external knee adductionmoment is a dynamic measure that occurs during the
stance phase of human ambulation. It acts to dispropor-
tionately distribute joint loads to the medial tibiofemoral
compartment [9] and is associated with radiographic knee
OA [10]. The first reported association between the knee
adduction moment and the cross-sectional area of the tib-
ial plateau was in 2004, when the knee adduction moment
during normal walking was significantly correlated with
the proximal medial tibial plateau bone cross-sectional
area in 20 healthy adult women (r = 0.63, P < 0.005) [11].
Since then, the knee adduction moment has consistently
been shown to be associated with the medial tibial plateau
bone size in knee OA [12, 13]. Mechanistically, this may
be an example of Wolff ’s law enabling subchondral bone
to better dissipate joint loads.
Obesity and subchondral bone cross-sectional area
Obesity is another factor that can increase knee joint load-
ing. Indeed, the unequivocal link between obesity and knee
OA [14, 15] may be due in part to the added mechanical
load imparted to bone by the excessive body mass. In a
cross-sectional study with a convenience sample of 372
adults, body mass index (BMI) was positively associated
with both the medial (7.1 mm2 kg per m2, P = 0.001) and,
to a lesser extent, the lateral (3.2 mm2 kg per m2, P =
0.037) tibial bone area [16]. Those who were obese
(BMI ≥30 kg/m2) also had greater medial tibial bone
area compared with normal weight subjects [16]. This
medial compartment predisposition suggests a local mech-
anical effect and further supports Wolff ’s law. Nevertheless,
it is also possible that obesity and bone area share common
pathways (for example, genetic), such that an increase in
one variable (for example, obesity) is paralleled by increases
in the other (for example, bone size). However, it is unlikely
that a larger tibial bone area is simply reflective of body
size, since this has been adjusted for in multivariate
analyses.
Joint derangement and subchondral bone cross-sectional
area
Bone adaptation also occurs when a joint cannot adequately
distribute external loads secondary to derangements in ar-
ticular structures. The primary role of the meniscii at the
knee is to cushion and redistribute joint loads. Therefore,
when the function of a meniscus is impaired by an anatom-
ical tear or extrusion, or menisectomy, joint load would be
expected to increase, with potential ramifications to sub-
chondral bone. It has been shown that meniscal surface
area strongly reflects the ipsilateral proximal tibial plateau
area [17], and meniscal tears and extrusions are associated
with greater bone area [18–20]. Similarly, it has been dem-
onstrated that individuals with anterior cruciate ligament
(ACL) tears have significantly larger bone surface areas in
the medial tibia and femur [21]. Nevertheless, it is unclear
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changes in menisci and ligament or vice versa. This was
partly answered in a study of knee OA, wherein baseline
medial meniscal extrusion was associated with increased
expansion of tibial plateau bone area over the course of 2
years [22].
Bone mineral density and the trabecular network
Bone mass and density at the knee can be studied by
measuring local periarticular bone mineral density (BMD)
with dual-energy x-ray absorptiometry and by using frac-
tal analysis to produce a description of trabecular bone
microarchitecture based on the cross-linkage, number,
and size of trabeculae [23, 24]. The literature examining
the response of bone architecture to mechanical loading
at the knee is inconsistent. Whereas some studies have
shown that periarticular BMD increases with increased
mechanical load [25–27], others have demonstrated
contrary findings, including a reduction in periarticular
BMD [28, 29].
However, the inconsistencies in the response of bone
architecture to mechanical load are likely attributable to
whether or not significant time has elapsed to enable bony
remodeling. For instance, in animal models of induced
knee OA, the acute and rapid resorption of periarticular
bone [28, 29] may simply be a reflection of the unaccus-
tomed and excessive loads that initially overburden bone.
However, after this acute insult, dynamic compensatory
changes that increase periarticular BMD likely occur [29].
The early resorptive phase may cause reduced bone mass,
predisposing microfractures with subsequent osteoblastic
activity and bone healing ultimately increasing BMD.
This time-dependent response of bone may explain why,
whereas animal models of acute OA demonstrate a reduc-
tion in periarticular BMD, epidemiological studies have
demonstrated that load is ultimately associated with an
increase in periarticular BMD.
Periarticular bone mineral density
Biomechanical variables and periarticular bone mineral
density Knee alignment is an important determinant of
periarticular BMD. Whereas varus deformity is associ-
ated with greater medial rather than lateral tibial BMD,
valgus deformity is associated with greater lateral tibial
BMD [25, 26]. In 69 people with medial tibiofemoral
knee OA, the proximal tibial BMD was also correlated
with the peak knee adduction moment [26].
Obesity and periarticular bone mineral density There
is a paucity of animal and human studies examining
the association between obesity and periarticular BMD
at the knee. Indeed, few data are available examining
the association between obesity and BMD at varied
anatomical sites, and despite the popular belief thatobesity may be protective against osteoporosis, this is
contentious [30–32].Joint derangement and periarticular bone mineral
density Akin to the increases in articular bone area ex-
pansion that occurs when menisci are damaged, it has
been shown that meniscal damage is also associated with
higher regional periarticular tibial BMD in the same com-
partment [27]. However, in the first 12 weeks after ACL
disruption in dogs, there is a rapid decrease in BMD in the
periarticular cancellous bone of the knee [28]. This corrob-
orates earlier work demonstrating a marked increase in
bone uptake at the knee approximately 5 weeks after ACL
disruption in a canine model of knee OA, signifying the
marked changes occurring in subchondral bone after joint
derangement [33].The trabecular network
Biomechanical variables and the trabecular network
Despite the proposition that, in skeletal biology, trabecu-
lae align with the orientation of dominant compressive
loads, this has not been widely tested and evidence sup-
porting this hypothesis is derived from animal studies. A
study of birds has shown that fine trabecular bone in the
distal femur has a high degree of correspondence be-
tween changes in joint angle and trabecular orientation,
supporting the prediction that trabecular bone adapts
dynamically to the orientation of the peak compressive
force [34]. Likewise, in mice, load was shown to signifi-
cantly increase trabecular bone volume at 8 weeks of
life, but modified trabecular organization with decreases
in trabecular bone volume was demonstrable in 12- and
20-week-old mice [35]. Whether this translates to human
bone biology is speculative, given the different kinematics
and kinetics of human locomotion.Obesity and the trabecular network Few studies have
examined the association between obesity and trabecular
structure at the knee (distal femur and proximal tibia) in
either humans or animals. In a study of adolescent black
females, it was found that obese people had a lower tra-
becular compartment area at the distal tibia than their
non-obese counterparts [36]. In a study comparing leptin-
deficient (ob/ob) and leptin receptor-deficient (db/db) fe-
male mice with wild-type mice, it was found that extreme
obesity caused by leptin impairment was associated with
reduced subchondral bone thickness and increased rela-
tive trabecular bone volume in the tibial epiphysis [37].
Nevertheless, reduced activity and joint loading observed
among obese subjects may be an alternate explanation
(that is, a confounder) to the relationships observed be-
tween obesity and trabecular network abnormalities.
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beculae are also affected by joint damage, and it has
been shown that there is lower apparent trabecular num-
ber with greater apparent residual trabecular thickness
and separation in people with meniscal tears [38]. In a
model of post-traumatic mouse OA induced by ACL rup-
ture, rapid loss of trabecular bone in the injured knee oc-
curred, followed by a partial recovery of trabecular bone
to a new steady state by 28 days after injury [29].
Evidence for bone adaptation to predate
maladaptive changes in articular cartilage
Bone and cartilage are intimately related since the avascu-
lar hyaline cartilage is reliant in part on the vascularized
subchondral bone to remain viable. Technetium scintig-
raphy work has demonstrated that increased bone metab-
olism is related to OA severity [39]. However, this does not
address the primary inciting event: does cartilage de-
struction initiate increased bone metabolism, or vice versa?
When animal models of induced OA and natural history
studies of humans have used MRI over the past decade
[3, 4, 20, 40, 41], they have generally demonstrated that
changes in subchondral bone precede cartilage degener-
ation. For instance, among animal studies, surgical damage
to subchondral bone leads to degradation in the overlying
cartilage in canines [3]. In another study [4], increased
thickness of the subchondral bone occurred prior to any
histologic evidence of cartilage degradation in a model of
spontaneously occurring knee OA.
Bone geometry and cartilage
Several in vivo human studies have examined the associ-
ation between tibial plateau size and changes in cartilage
volume. In a population study of 324 adults, larger base-
line proximal tibial bone area was associated with increased
cartilage volume loss over the course of 2 years at both the
medial and lateral tibial sites [40]. Nevertheless, adjusting
for baseline cartilage volume or the presence of osteophytes
attenuated results, suggesting that the presence of OA or
very early structural damage within the joint may be a key
mediator of the response of cartilage to a larger bone size.
However, it is important to note that these findings were
unlikely to be confounded by the stature of a person, since
multivariate analyses adjusted for both gender and BMI. In
the same population, larger baseline proximal tibial bone
area was associated with worsening cartilage defect scores
[41]. In symptomatic knee OA, knee cartilage defects
tended to progress with time, and increased proximal
tibial bone area was a determinant of such progression
[20]. Since cartilage defects and volume loss predict the
development of radiographic knee OA and joint replace-
ment surgery [42], these data may implicate the tibial
plateau size as an important early target in the prevention
of knee OA [42].Bone mineral density, architecture, and cartilage
Several studies have shown a positive association between
BMD at a number of sites, including total body, femur,
and spine, and knee cartilage volume [43–45]. However,
these studies have not focused on localized periarticular
BMD at the subchondral interface of the knee, arguably
the most important anatomical region in OA.
In people with established knee OA, it has been shown
that the medial-to-lateral tibial BMD ratio was positively
associated with medial joint space narrowing [46]. Like-
wise, periarticular BMD at the knee in people with knee
OA was significantly correlated with future joint space
narrowing [47] and predicted medial knee cartilage de-
fect development [48]. In an animal model of induced
knee OA, mice that had their ACL ruptured demonstrated
rapid loss of trabecular bone in the first week after injury
but recovered by 28 days [29]. By day 56, there was con-
siderable non-native bone formation and evidence of de-
terioration in histologic grading of articular cartilage [29].
The trabecular structure of bone also appears to be a
determinant of cartilage changes at the knee. In an in-
duced model of knee OA in guinea pigs, trabeculae were
thicker and further apart and topographically mirrored
untoward histomorphometric changes in cartilage [49].
In women with established knee OA, vertical oriented base-
line subchondral trabecular bone integrity of the medial
tibia, as determined by fractal analysis, predicted both med-
ial joint space narrowing on radiographs and medial tibial
cartilage volume loss from MRI [50]. Likewise, in people
with end-stage knee OA requiring total knee replacement
surgery, reduced trabecular spacing was correlated with a
decreased joint space width [51].
Cartilage response to systemic bone mineral density
may vary according to disease status. There is conjecture
as to whether a higher systemic BMD is to the benefit or
detriment of cartilage. This may differ on the disease state
(that is, initiation versus progression of disease). A large
radiographic study (n = 1,754) demonstrated that high
systemic BMD increased the risk for incident knee OA,
as measured by the onset of joint space narrowing [52].
However, in the only longitudinal MRI study, a high
total body BMD was associated with an increase in femoral
cartilage thickness, and a high spine BMD was associated
with increases in femoral and lateral tibial cartilage thick-
ness in subjects with OA [53]. This raises the possibility
that the influence of bone health parameters, such as
BMD, may differ on the disease state whereby a high sys-
temic BMD may predate disease initiation but may help to
protect against disease progression.
A disease paradigm for primary and secondary
knee osteoarthritis
Although OA is a heterogeneous disease with multiple path-
ways of varied etiologies leading to a common endpoint of
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with a common final pathway of cartilage damage in
both primary and secondary knee OA. In secondary knee
OA, we base our disease paradigm on evidence collated
from animal studies which, via trauma, induce OA (Fig. 1).
An initial acute insult to the knee, such as an ACL rup-
ture, leads to a sudden overburdening of periarticular
bone and a resorptive phase [28, 29]. This may initially
cause a transient “osteoporosis-like” state, as has been
demonstrated in dog and mouse models of OA [28, 29].
This overburdening of periarticular osteoporotic bone
may result in microfractures and a compensatory shift
toward an osteoblastic state to promote fracture healing
that ultimately results in an increase in periarticular BMD
[28, 29]. These changes therefore appear time-dependent.
This is exemplified in a mouse model of OA, in which
there was rapid loss of trabecular bone 7 days after
knee injury. However, partial recovery of bone to a newFig. 1 Hypothesized disease paradigm for early traumatic secondary knee ostestate occurred by 28 days, and by day 56, considerable
non-native bone formation had occurred [29]. Moreover,
in a canine model, the regions of pronounced BMD loss
corresponded to the area of focal cartilage defects [28].
In parallel with these changes, trabeculae network remod-
eling occurs with subsequent downstream effects on car-
tilage loss [49–51]. Therefore, although these adaptations
may ultimately enable bone to better redistribute mechan-
ical load, they inadvertently predispose cartilage degener-
ation. This may occur in part via impairment of flow of
nutrients to the avascular hyaline cartilage via the scler-
osed subchondral interface [54], thus setting up a trajec-
tory of early knee OA.
Traumatic secondary OA has an evidence base derived
from animal models, but there is a paucity of animal stud-
ies examining the more chronic course of primary knee
OA. As such, there is less evidence to substantiate any
theories underpinning bone changes in primary OA.oarthritis (OA). ACL anterior cruciate ligament, BMD bone mineral density
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ease pattern may follow a more insidious progression
that is similar to that hypothesized for secondary OA. In
secondary OA, an inciting event such as an ACL rupture
causes an acute increase in mechanical load, but we
speculate that a more subtle and chronic increase in joint
load, such as that imparted by obesity or a change toward
knee malalignment, occurs in primary knee OA.
Nevertheless, it is also possible that, in primary OA, a
multitude of other bone adaptations which do not in-
voke a resorptive state are occurring. For instance, rather
than resulting in insufficiency fractures, insidious meta-
physeal bone expansion of the proximal medial tibial
plateau in response to increased joint loads or obesity
[11–13, 16] may cause increased subchondral bone area
in an attempt to better redistribute joint loads. It is also
possible that, as bone area expands, cartilage begins to
thin and that fissuring and defects precede volume loss.
Alternatively, metaphyseal surface area expansion may
impair the mechanical stimulation required for cartilage
to remain viable. For instance, in its most extreme form,
marked cartilage volume loss occurs after forced immo-
bility such as that induced by spinal cord injury [55, 56].
Therefore, changes in the bone cross-sectional area may
enable bone to better redistribute joint loads but may de-
crease contact pressure on articular cartilage, and insidi-
ous but accelerated volume loss may result [56]. Although
these paradigms are likely to be oversimplified, the princi-
ples of primary and secondary OA may follow a similar
trajectory that ultimately ends in an adaptive response of
bone but in a maladaptive downstream effect and final
common pathway of cartilage loss.
Potential disease-modifying osteoarthritis drugs
Because periarticular bone changes predate deleterious
cartilage changes [20, 40, 41, 57], it has been speculated
that drugs targeting bone may have a disease-modifying
effect in OA. Indeed, to date, the drugs that arguably
show most promise as disease-modifying osteoarthritis
drugs (DMOADs) all target bone.
Anti-resorptive drugs
Bisphosphonates
Human studies of progressive knee OA, as determined
by joint space narrowing of at least 0.6 mm, demonstrated
maintained or improved bony trabecular structure at the
knee if risendronate 15 mg/day or 50 mg/week was given,
respectively [58]. To the best of our knowledge, three
randomized controlled trials have examined the role of
bisphosphonates in people with knee OA [59–61]. In
the Knee OA Structural Arthritis (KOSTAR) study, a
dose-dependent reduction in the level of C-terminal cross-
linking telopeptide of type II collagen (CTX-II) was seen in
subjects receiving risedronate [60]. Nevertheless, comparedwith placebo, risedronate did not improve signs or
symptoms of knee OA nor did it alter the radiographic
progression of disease. The British Study of Risedronate
in Structure and Symptoms of Knee OA (BRISK) exam-
ined 5 or 15 mg of risedronate in people with mild to
moderate medial knee OA over the course of 12 months
[61]. The experimental arm in the BRISK study, in con-
trast to the KOSTAR study, showed significantly greater
improvements in pain with a trend toward attenuation of
joint space narrowing. Both KOSTAR and BRISK demon-
strated reduced CTX-II in the bisphosphonate group, and
the BRISK trial also showed reduced urinary N-terminal
cross-linking telopeptide of type I collagen, a marker of
bone resorption. However, radiographic assessment of the
joint space is an insensitive and non-direct measure of ar-
ticular cartilage. No MRI study has examined cartilage
volume as an endpoint in bisphosphonate studies of knee
OA. In the only randomized trial which used MRI to in-
vestigate subjects with symptomatic knee OA and known
bone marrow lesions (BMLs), zolendronic acid was shown
to reduce BML size and knee pain at 6 months, and there
was a trend toward reduced BML size at 1 year [59].
Strontium ranelate
Recent interest in strontium ranelate as a DMOAD stems
from a double-blind randomized placebo-controlled trial
[62]. In this study, fewer people treated with strontium
ranelate demonstrated radiographic progression of knee
OA than those treated with placebo, as determined by
joint space narrowing. In the Strontium Ranelate Efficacy
in Knee Osteoarthritis Trial (SEKOIA), MRI was used to
assess patients with knee OA treated with strontium rane-
late over the course of 36 months [63]. Compared with
placebo, patients who received 2 g/day of strontium rane-
late were found to have significantly reduced cartilage
volume loss and progression of medial compartment
BMLs. In a recent study of dogs with ACL transection,
strontium ranelate significantly reduced cartilage lesions
at all doses tested (25, 50, or 75 mg/kg per day), but better
preservation of the collagen network was seen in dogs that
received 50 and 75 mg/kg per day [64]. Subchondral bone
thickening observed in placebo dogs was also reduced by
strontium ralenate at 50 mg/kg per day.
Calcitonin
Calcitonin is produced primarily by the thyroid and acts
to reduce blood calcium levels, opposing the effects of
parathyroid hormone (PTH). Both animal and human
studies have shown promising data supporting calcitonin
in mitigating the symptoms and structural changes of
OA. A recent animal study examined the efficacy of calci-
tonin on the progression of early-stage OA in a surgically
induced model of OA among rabbits [65]. Intramuscular
administration of calcitonin delayed the progression of
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that transgenic mice overexpressing calcitonin had higher
bone volume and were protected against cartilage ero-
sions [66]. Another study examining dogs concluded
that by counteracting bone loss, calcitonin reduced cartil-
age lesions [67].
Among human studies, post-menopausal women with
moderate to severe painful radiographic knee OA treated
with intranasal calcitonin demonstrated improved pain,
stiffness, and function after 3 months of treatment and
these improvements remained consistent for 1 year [68].
Moreover, need for rescue analgesia was reduced by ap-
proximately 60 % by 12 months of treatment. In a small
randomized controlled trial, it was shown that oral calci-
tonin at a dose of 1 mg/day reduced functional disability
and reduced levels of biomarkers CTX-II and matrix
metalloproteinase 1 [69].Parathyroid hormone
PTH has been shown to act via the type 1 PTH receptor
to induce matrix synthesis and suppress maturation of
chondrocytes [70]. It was found that, when the ability of
PTH analogues to inhibit the terminal differentiation of
human articular cartilage in vivo was exploited, a PTH
analogue (PTH[1–34]) reduced OA-like changes by decreas-
ing type II collagen and glycosaminoglycan content
while increasing type X collagen and chondrocyte apop-
tosis in rats [70]. Moreover, in a mouse study, PTH[1–34]
inhibited aberrant chondrocyte maturation and associated
articular cartilage degeneration after induced injury
[71]. Whereas immediate systemic administration of
PTH[1–34] increased proteoglycan content and inhibited
articular cartilage degeneration, delayed treatment induced
a regenerative effect. It was concluded that PTH analogues
may be useful for decelerating cartilage degeneration and
inducing matrix regeneration in people with OA. In a
rabbit model of OA preceded by osteoporosis, PTH[1–34]
reversed areas of decreased bone area, trabecular thick-
ness, and cartilage damage severity [72]. Human studies
are lacking.Conclusions
As theorized by Wolff ’s law, when knee bone is subject
to increasing loads, it responds with compensatory
geometrical changes, most notably an expansion in sub-
chondral bone cross-sectional area. Paralleling these geo-
metric changes is the remodeling of bone architecture
with a long-term increase in periarticular BMD and re-
modeling of the trabeculae network. Although these adap-
tive bone changes help bone to better cope with increased
joint loads, they also appear to inadvertently predate mal-
adaptive responses in other joint structures, most notably
hyaline articular cartilage.A potential mechanism for DMOADs may be at the
level of various methods of inhibiting bone resorption.
After acute injury, such as ACL rupture, animal models
of OA have consistently demonstrated a rapid increase
in localized periarticular bone resorption. We have specu-
lated that this acute period likely represents an overbur-
dening of bone by a sudden increase in mechanical load.
However, as bone adapts, compensatory mechanisms,
such as an increase in periarticular BMD, secondary to
microfractures may enable the bone to withstand in-
creased bony loads. It is speculated that anti-resoprtive
therapies such as bisphosphonates and strontium rane-
late may have a DMOAD effect by inhibiting this initial
resorptive phase of overburdened periarticular bone. Alter-
natively, other bone-modifying agents such as calcitonin
and PTH analogues are attracting increasing attention
as potential DMOADs. Further work is required to examine
novel therapeutic agents that may have a bone-modifying ef-
fect, and therefore a disease-modifying effect, in knee OA.
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